Dopamine, immunity, and disease
B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - ASPET
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …
regulating many processes including reward, movement, and cognition. Dopamine also …
Dopamine: functions, signaling, and association with neurological diseases
The dopaminergic system plays important roles in neuromodulation, such as motor control,
motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a …
motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a …
Enhanced uptake of BPA in the presence of nanoplastics can lead to neurotoxic effects in adult zebrafish
Plastic particles have been proven to be abundant in the aquatic environment, raising
concerns about their potential toxic effects. In the present study, we determined the …
concerns about their potential toxic effects. In the present study, we determined the …
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue
R Brisch, A Saniotis, R Wolf, H Bielau… - Frontiers in …, 2014 - frontiersin.org
Dopamine is an inhibitory neurotransmitter involved in the pathology of schizophrenia. The
revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and …
revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and …
The physiology, signaling, and pharmacology of dopamine receptors
JM Beaulieu, RR Gainetdinov - Pharmacological reviews, 2011 - ASPET
G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the
physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from …
physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from …
Monoaminergic neuropathology in Alzheimer's disease
None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …
patterns of the neuropathological changes at the cellular and regional levels, and their …
[HTML][HTML] Focus: The Aging Brain: Side effects of a dopamine agonist therapy for Parkinson's disease: A mini-review of clinical pharmacology
JA Borovac - The Yale journal of biology and medicine, 2016 - ncbi.nlm.nih.gov
Dopamine agonists (DA) are therapeutic agents that are commonly used in the treatment of
Parkinson's disease (PD). They can reduce undesired motor fluctuations and delay the …
Parkinson's disease (PD). They can reduce undesired motor fluctuations and delay the …
Regulation and function of selenoproteins in human disease
FP Bellinger, AV Raman, MA Reeves… - Biochemical …, 2009 - portlandpress.com
Selenoproteins are proteins containing selenium in the form of the 21st amino acid,
selenocysteine. Members of this protein family have many diverse functions, but their …
selenocysteine. Members of this protein family have many diverse functions, but their …
Bioconcentration and transfer of the organophorous flame retardant 1, 3-dichloro-2-propyl phosphate causes thyroid endocrine disruption and developmental …
Q Wang, NLS Lai, X Wang, Y Guo… - … science & technology, 2015 - ACS Publications
Organophosphate flame retardants are emerging environmental contaminants, although
knowledge of their health risks is limited. Here, thyroid hormone homeostasis and neuronal …
knowledge of their health risks is limited. Here, thyroid hormone homeostasis and neuronal …
Removing obstacles in neuroscience drug discovery: the future path for animal models
A Markou, C Chiamulera, MA Geyer… - …, 2009 - nature.com
Despite great advances in basic neuroscience knowledge, the improved understanding of
brain functioning has not yet led to the introduction of truly novel pharmacological …
brain functioning has not yet led to the introduction of truly novel pharmacological …